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Depression, or major depressive disorder, has affected how people think, feel, and 
behave. As well as psychological problems, depression has also been a comorbid factor 
in other emotional and physiological disorders. The actual cause of depression is 
unknown. Researchers have worked to understand the connections and conditions a 
person may experience for depression to develop. One commonly researched path to 
depression is vitamin deficiency. A variety of vitamins like B6, B12, folate, and vitamin 
D have been linked extensively to depression as a possible cause. A continuation of 
research expands into how a deficiency of these vitamins causes depression. Low levels 
of these vitamins are associated with taking birth control and other medication, nutrition, 
diet, and disorders. Several research studies have led to understanding biological 
pathways and determined that vitamins such as B6, B12, and folate share a common 
pathway, homocysteine metabolism. Reduced levels of these vitamins have caused an 
increased level of homocysteine. An increased concentration of homocysteine is 
associated with depression, cerebrovascular disease, and monoamine neurotransmitters.  
A combination of these effects has led to the creation of a hypothesis: high 
homocysteine levels can cause cerebral vascular disease and neurotransmitter deficiency 
resulting in a depressed mood. In this paper, depression is explored through the lens of 
homocysteine metabolism, the cause of the pathway’s dysfunction, and if vitamin D is 







Depression is a significant impairment in social and occupational functioning (9). 
Depression's cause is unknown but may have developed from a variety of conditions. 
Rather than a single force that has affected mood, research agrees that several elements, 
such as social, psychological, and biological factors, interact with one another to result in 
depression. (1, 21, 22). A factor commonly discussed is vitamin deficiency and nutrition 
that can lead to depression. Vitamins that act as catalyzing cofactors like folate, B6, and 
B12 are related to mood and cognitive performance, and a deficiency could negatively 
affect mental state (15). Other vitamins such as vitamin D and its metabolites are 
involved with various psychiatric disorders. Insufficient vitamin D levels are associated 
with anxiety and depression because of their brain and nervous system health. Like B 
vitamins associated with depression, nutrition and vitamin D are possible risk factors for 
developing depression-like symptoms. In addition to nutrition, however, sun exposure 
plays a crucial role in vitamin D and adds another environmental factor that can cause a 
deficiency and a risk for depression (23). Whether it is nutrition, sun exposure, or trauma 
experienced in early life when added to having certain genes, the environment's role can 











Vitamin levels connected to depression include vitamin D, folic acid, vitamin B6 
(pyridoxal phosphate), B12, zinc, and copper (3, 2,). Below normal vitamin B levels have 
influenced memory negatively and are connected to cognitive impairment and dementia. 
Vitamin B levels also contribute to an unstable mood, namely depression (2). Both 
vitamins B6 and B12 are involved in a metabolic pathway for homocysteine metabolism. 
Within the pathway are other substances that have a role in mood regulation and 
depression, specifically, homocysteine and S-Adenosylmethionine (SAM) (5). 
Homocysteine (Hcy) is an agent involved in the production of neurotransmitters and 
activation of NMDA receptors. Evidence has shown that dysfunction of these receptors 
and neurotransmitters, glutamate, and glycine, has provoked damage in the brain, namely 
the hippocampus (19). In the context of depression, the hippocampus is a commonly 
studied brain structure. The role of the hippocampus is stress regulation, involvement in 
cognitive processing, and connections with the limbic and prefrontal regions (9). Damage 
and reduction of a functional hippocampus have been used as a marker observed in 
depression. Persistent reduction during the lifespan could further increase vulnerability 
(9). 
A deficiency in the B6 vitamin can directly impact function by causing abnormal 
homocysteine levels (5). Hyperhomocysteinemia is associated with many diseases and 




Alzheimer's. Also connected to homocysteine metabolism are complications with 
pregnancy and congenital disabilities (6).  
Researchers have found that folate, a byproduct when homocysteine is converted 
to methionine by B12, has a lower serum level in patients with depression. A high 
prevalence of a deficiency has also been documented in patients with other psychiatric 
conditions such a bipolar disorder and cognitive dysfunction disorders (11,10, 15). 
Figure 1. Homocysteine Metabolism 
The biological pathway of homocysteine metabolism includes many different linkages to 
depression. A deficiency in B6 and B12 vitamins will lead to an increased level of homocysteine. 
Both methionine and S-Adenosyl Methionine have stress and antidepressant properties that are 
therefore decreased with a B vitamin deficiency.  
 
Abnormal behavior has been observed when zinc and copper levels are affected. 




primary excitatory neurotransmitter in the cerebral cortex. A decreased level of zinc and 
copper will affect these receptors, leading to a decrease in impulses or abnormal NMDA 
activity, which could implicate abnormal behavior and cortical functioning (3).  
Depression also has a relationship with vitamin D. Vitamin D's relationship has 
been related and driven by homeostatic, trophic, and immunomodulatory effects of 
vitamin D, suggesting a role in pathophysiology. A deficiency may also be attributed to a 
consequence of depression-related symptoms like reduced outdoor activities, sun 
exposure, and dietary changes. (12, 13). Receptors of vitamin D are distributed in many 
areas in the brain, including the limbic system, cerebellum, and cortex. These structures 
are involved in emotional processing and affective-related disorders such as depression 







Figure 2. Vitamin D’s Role in Managing Depression-like symptoms 
The role of vitamin D has multiple relationships with managing phenotypic signs of depression. 
This includes control of calcium homeostasis, expression of antioxidant genes, control of 
serotonin formation, inflammation, mitochondrial function, and epigenetics through 
demethylases. 
Developing depression is reduced in individuals with a high serum level of 
vitamin D. Control of mood associated with vitamin D ranges from calcium level control, 
expression of genes, serotonin manufacturing, control of inflammation, and 
mitochondrial function. In Figure 2, there are six controls of vitamin D that allow for 
mood regulation. These functions are critical to maintaining a normal and healthy number 
and function of neurons in the nervous system (27).  
One of the mood controls that occur through absorption of vitamin D is calcium 




When vitamin D levels are low, there will be a higher calcium level. Control of calcium 
levels associated with vitamin D is linked to various channels that buffer and extrude 
calcium, such as calbindin and parvalbumin. Most notably, however, is vitamin D's 
involvement with the channels in the hippocampus associated with calcium levels, L-type 
CaV1.2 and L-type CaV1.3. Deficient vitamin D levels impact these receptors, leading to 
elevated calcium levels in the hippocampus, which researchers have found linked to 
bipolar depression (27). 
Depression has also been found to be related to antioxidant genes. For example, 
the antioxidant pathway NRF2. Dysfunction of this gene and pathway produces 
neurodegenerative, cardiovascular, pulmonary, and chronic inflammation problems, 
leading to depression-like symptoms (28 and 29). This pathway functions explicitly to 
defend against oxidative or electrophilic stress by triggering proteins through the 
expression involved in eliminating these agents (30). An article published on this 
pathway indicated that Nrf2-null mice have an endogenous state of oxidative stress and 
are vulnerable to depression due to the imbalance of toxic products in the cell (29). The 
NRF2 pathway is related to seasonal depression symptoms, likely from a decrease in the 
sun during the winter months (28).  
Vitamin D also plays a role in the inflammatory process (28). Inflammation and 
depression have already been connected; in fact, low-grade inflammation will trigger a 
change in patients' mental and physical health already diagnosed with major depression. 
Likely, inflammation promotes susceptibility to depression (31). Typically, physical 
stress like damage to cells or infection causes inflammation; however, psychological 




Another aspect of vitamin D’s linkage to depression is that it controls the expression of 
mitochondrial proteins. A deficiency of vitamin D leading to a lower level of 
mitochondrial function will directly impact mood (28). If the mitochondria and oxidative 
phosphorylation are compromised, neurons cannot meet their energy demand. Chronic 
stress inhibits mitochondrial OXPHOS, dissipates membrane potential, and damages the 
organelle in many brain regions, influencing the hippocampus, the cortex, and the 
hippocampus. Successful adaptation to stressful conditions is also compromised with 
mitochondrial dysfunction. Exposure to many different situations that exert stress can 
lead to ROS production, increased proinflammatory cytokines, and decreased antioxidant 
enzymes, which are other controls of mood associated with vitamin D (33).  
Vitamin D controls the expression of DNA demethylases, which control gene 
transcriptions to maintain regular neuronal activity and prevention of depression (28).  
Finally, vitamin D is also involved in the formation of serotonin. Vitamin D is directly 
responsible for the increased tryptophan hydroxylase 2 (TPH2) level while repressing 
tryptophan hydroxylase 1 (TPH1). This enzyme has direct involvement in the synthesis 
of tryptophan to serotonin. Additionally, to vitamin D is involved in serotonin synthesis, 
vitamin B6 and B12 are also involved and are shown in Figure 3 to be essential for 
synthesizing tryptophan to 5-HTP and 5-HTP to serotonin.  
 In addition to serotonin synthesis, Vitamin D’s role, indicated in Figure 2, in 
mood regulation relates to the function of the homocysteine metabolism (14). Figure 3 
provides a comprehensive overview of vitamin deficiency and how the vitamins 




combined in significant ways and indicate that these are essential vitamins responsible for 
a regulated mood.  
 
Figure 3. Deficiencies of Vitamin D, Vitamin B12 and B6, and Folate/Folic Acid and their 
Involvement in Depression 
Vitamin B6, B12, and Folate are components of the homocysteine metabolism. All three, folate 
taking the form of folic acid also are involved in the synthesis of serotonin. The three of these 
vitamins also share a relationship with Vitamin D. Vitamin D regulates the expression of TRPH2, 
the enzyme and rate limiting step responsible for serotonin synthesis. Vitamin D’s roles for mood 
regulation have similar, or nearly identical, outcomes as the homocysteine metabolism. 
 
Adverse Effect of Depression Caused by Medication  
Medications that have caused depression as an adverse effect are treatments for 
acid reflux, allergies, anxiety, birth control, blood pressure, and pain. Additionally, a 




increased likelihood of developing depression (7, 22). Researchers have found that 
homocysteine is affected by the use of birth control. Birth control's influence on 
homocysteine levels has also induced sporadic ovulation and hormonal changes. These 
risks and others like vascular disease are more likely to occur in users of oral 
contraceptives (OC). OCs made primarily with synthetic estrogen have caused B6, B12, 
and folate (19, 8, 22). In the absence of B12, conversion from Hcy to SAM, which has 
antidepressant properties, is affected (19).  
Across the life cycle, hormonal fluctuation increased the risk of depression in 
women, specifically ovarian hormones. OC use and depression have shown a decreased 
tryptophan oxidase resulting in a vitamin B6 deficiency. OC use has been known to cause 
zinc and copper deficiencies, nutrients involved in cortical functioning. Zinc and copper 
are associated with glutamate receptors; decreased levels of these nutrients may produce 
abnormal behavior and cortical functioning (21).  
Researchers have shown that mood-related disorders such as depression are more 
frequently related to women and are connected to alterations with sex hormone 
production. This includes birth control, undergoing hormonal replacement therapy, and 
menopause. Estrogen imbalance significantly can contribute to depression and induce 
long-lasting effects on brain function and gene expression (34). 
Medical Conditions, Genetics, and Vitamin Deficiency 
Studies that investigated Autism have shown that many children diagnosed have a 
low B6 vitamin (3). And a decreased folate level is associated with depression and 




involved in homocysteine metabolism. MTHFR polymorphisms have shown a significant 
impact in developing diseases and disorders when there is a reduction of enzyme activity. 
Specifically, MTHFR dysfunction has been linked to anxiety, depression, positive or 
negative symptoms of schizophrenia, Autism, and bipolar disorders (20).  
Also associated with Autism is vitamin D. A vitamin D deficiency could be 
explained by nutrition and or exposure to light, but it also can be considered a risk factor 
for impaired brain development (35). Additionally, vitamin D deficiency in Autism can 
disrupt the serotonin pathway. Autism's link to serotonin is serotonin's promotion for 
prosocial behavior and emotional, social cue assessments, common symptoms or issues 
within the Autism community (36).  
Diseases like cystic fibrosis, Crohn's disease, and celiac disease can cause a 
vitamin D deficiency (43). More generally, irritable bowel syndrome (IBS) is associated 
with a vitamin d deficiency. Vitamin D deficiency has been linked to depression and 
colorectal cancer, sclerosis, and several other pathologies when combined with 
inflammatory bowel diseases (37). Therefore, a deficiency of vitamin D increases the risk 
of depression and other additional medical problems.  
Diet and Depression  
 As discussed in the previous sections, vitamins are essential in mood regulation. 
An essential part of maintaining the correct balance of nutrients and vitamins is diet. 
Food patterns that lead to vitamin deficiency and then to depression are the same that 
occur during depression. Diet during a depressive episode or major depressive disorder 




foods (50). Researchers had found that a reduced risk of developing depressive symptoms 
was associated with a healthy diet (46). Diet alone is related to inflammation, oxidative 
stress, and brain plasticity, all of which are factors in depression. Specific diets with high 
consumption of processed food, a high intake of refined grains, and food with high sugar 
and high-fat content like the Western diet have been associated more closely with 
depression than alternative lifestyles (45). Decreased vitamin levels linked with the 
Western diet are commonly the vitamins discussed in this paper, such as vitamin D and 
B-vitamins (47). Previous studies have shown that diet may have a significant effect on 
the treatment and the prevention of depression.  
 Additionally, the Mediterranean diet is noted as the diet that significantly 
improved mental health in adults with depression (49). The diet has high nutrient levels 
of B vitamins, vitamin D, and folic acid, which are all vitamins involved directly in 
serotonin synthesis (44). Therefore, an unhealthy diet has been considered a predisposing 
factor for depression based on vitamin deficiency, and a change in diet could directly 
result in mental health.  
Vitamin Supplement Treatment 
Antidepressants have come with a range of complications and adverse effects that 
could call for new strategies or interventions. Vitamin supplementation for patients with 
depression has been a subject of research to understand and identify vitamin pathways 
and their relationship to depression. Vitamin supplementations are defined by "ad-on" 
strategies with antidepressant treatment and delaying the onset of depression (14 and 38). 




depressive episodes. Supplementation with these vitamins has also reduced the risk of a 
recurring episode.  Furthermore, a study highlighted that there was mood improvement 
associated with higher B6 levels. Regarding B12, the study noted that adolescents with a 
borderline level of B12 deficiency started to develop signs of cognitive changes 
indicating the importance of B12 in cognitive function (50). Previous research has 
implicated and suggested that folate supplementation improved the efficacy of 
antidepressants. Most researchers and studies have used folic acid as a supplement and 
found reduced symptoms of depression and improved cognitive function. (10, 11, 16, 50). 
Since then, there has been an expansion in the research of vitamin supplementation. 
Evidence has supported that supplementation may be more helpful for the long-term 
management of depression (15). Low folate levels in patients with depression have also 
been linked to poor response to antidepressants, and the additional supplement of folate 
has been shown to improve a better treatment outcome (16 and 50). Trials involving 
folate and vitamin B12 have suggested that a treatment of 0.8 mg of folic acid a day or 
0.4 mg of vitamin B12 a day have demonstrated decreased depression symptoms (50). 
Vitamin D supplementation in combination with antidepressants was also used to 
treat and reduce depressive symptoms effectively.  In a study, researchers found that 
vitamin D supplementation had increased the blood vitamin serum levels and improved 
the mood of participants either mildly or moderately (38). Deficiency of this vitamin is 
expected in the elderly, adolescents, individuals that are obese and do not get enough 
outdoor exercise, are homebound with limited sun, and people with chronic illness. These 
groups of people are known as a risk for depression and may benefit from vitamin D 




vitamin D supplementation to treatment is depression's multifactorial origins. 
Depression's origins are related to other purposes of vitamin D, such as inflammation 
reduction, antioxidant influence, and involvement with mitochondrial function (39).  
Adding vitamin D as a treatment has numerous benefits in treating someone with 
gastrointestinal disorders. Syndromes like irritable bowel syndrome (IBS) can lead to a 
vitamin D deficiency, and quality of life may improve with vitamins added to the 
treatment (37). A person diagnosed with autism may be treated with a supplement of B6. 
Studies have shown that patients had increased appropriate behaviors when provided 
supplements compared to children who did not receive a supplement (3). Due to their 
deficiency, these disorders could lead to depression, so supplementation with the other 
appropriate medication may reduce the risk of depression.  
In addition to depression treatment, research has also proved that nutritional and 
herbal supplementation is an effective method for treating anxiety and anxiety-related 
conditions without the side effects of medication (48).  The conclusion drawn in a 
literature review shows that psychological conditions could be treated or alleviated by a 
more natural treatment than traditional Western medicine.  
COVID-19, Stress, and Vitamin Deficiency 
Health problems such as stress, anxiety, depressive symptoms, insomnia, denial, 
anger, and fear rose during the outbreak of the COVID-19 pandemic (41). The pandemic 
resulted in stress worldwide to people without and people with mental illness. Based on 
estimates in a previous study, exposure to recent significant life stress has been 




prevalence of mood disorders and depression-like symptoms before the pandemic found a 
three-fold higher symptom prevalence during the pandemic. An increased amount of 
stressors such as stay-at-home orders, unemployment, and concern about the virus could 
have caused physical, emotional, and psychological harm, which indicated that the 
COVID-19 pandemic itself could be considered a traumatic event (42).  
The social signal transduction theory of depression is a hypothesis that could be 
applied to this impact of the pandemic. According to this theory, experiences of social 
threat and adversity can increase inflammation, and that this inflammation could have a 
role in depression through proinflammatory cytokines (40). Due to constrictions of the 
pandemic, fewer people were going outside, and therefore not getting enough sun 
exposure. Lack of this for the human body could result in a vitamin D deficiency, a 














Strategies involved were using a search engine such as PubMed, Google Scholar, 






 When it comes to depression, there has never been a single force responsible for 
the disorder; instead, it occurs due to the combination of several elements. Vitamin 
deficiency has proved to be an element contributing to depression, and vitamin 
supplementation can be a possible add-on treatment for depression through years of 
research. The most notable vitamins were vitamins B6, B12, and folate and are 
components of homocysteine metabolism. A deficiency of these vitamins has led to 
dysregulation of homocysteine metabolism associated with moods. In homocysteine 
metabolism, products such as methionine and S-Adenosyl Methionine have direct effects 
on mood regulation. When the products are not formed or have decreased levels, 
depression symptoms could develop. As well as homocysteine metabolism, vitamin B6 is 
also related to the synthesis of serotonin. Therefore not only could a B6 deficiency cause 
depression from influencing the homocysteine metabolism, but it could further cause 
damage in the serotonin synthesis pathway. 
 Another vitamin that has a strong link to serotonin synthesis is vitamin D. In 
serotonin synthesis, vitamin D regulates the rate-limiting step and, therefore, directly 
affects the serotonin levels.  Vitamin D is also involved in several other processes linked 
to the development of depression, such as antioxidants, mitochondrial proteins, and more. 
The metabolic processes and the vitamins involved can be affected by medication, 
including oral contraceptives, nutrition, medical conditions, and genetics. 
 Treatment for depression with supplements of vitamin B6, B12, and folic acid 




someone diagnosed with depression also reduced the risk of recurrent depressive 
episodes. Folate significantly has improved the use of antidepressants, and most 
researchers found that folic acid had reduced signs of depression and improved cognitive 
function. Vitamin D supplementation in combination with antidepressants had also been 



















RECOMMENDATIONS FOR FUTURE STUDIES 
Vitamin deficiency and depression remain a topic in research that still needs to be 
studied. In this paper, many studies were brought together to show how a vitamin 
deficiency can change the processes in the body that are responsible for mood regulation. 
However, in this topic, many studies explain that adding vitamin supplementation into 
treatment for depression does not create any significant positive result. In addition to 
whether or not vitamins help symptoms of depression, an area not discussed in this paper, 
dosage volume, needs to be further researched. Several reviews have suggested that 
dosage needs should be evaluated, and dosage regarding the severity of depressive 
disorders should be further expanded. 
Discussed in this paper were the ways that vitamin levels are affected. Vitamin 
levels are affected by oral contraceptives, causing depression-like symptoms, and remains 
to have little research. In most studies, there is no definite answer as to why oral 
contraceptive use causes these vitamin level fluctuations, and, therefore, no real 
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